Pannha Kongbouakhay

Pannha Kongbouakhay has a diverse range of work experience in the healthcare industry. Most recently, they worked as a Field Applications Scientist at RareCyte, Inc., a well-funded life sciences company focused on the development of technology to detect and characterize rare cells in blood. Prior to that, Pannha held the position of Senior Field Applications Specialist at Beckman Coulter Diagnostics, where they were involved in the development and marketing of biomedical testing products used in hospitals and critical care settings.

Before transitioning to these roles, Pannha worked as a Medical Technologist at Broadway Medical Clinic, where they gained experience in medical laboratory procedures and practices. They also served as a Medical Laboratory Scientist at Baylor Scott & White Health, where they utilized their technical expertise to deliver accurate data and results to clinicians and physicians. Additionally, Pannha worked as a Medical Laboratory Technician at HEALTHCARE ASSOCIATES OF IRVING LLP and Las Colinas Medical Center, further solidifying their laboratory skills and knowledge.

Overall, Pannha Kongbouakhay has a strong background in medical technology, laboratory procedures, and the development of diagnostic tools.

Pannha Kongbouakhay began their education journey in 2010 by obtaining an Associate of Science degree in Clinical Laboratory Science/Medical Technology/Technologist from Tarleton State University, which they completed in 2012. Following this, Kongbouakhay pursued a Bachelor of Science degree in the same field at the University of Texas Medical Branch. Their degree program lasted from 2012 to an unspecified end date.

In 2014, Kongbouakhay attained the certification of Medical Laboratory Scientist (ASCP-MLS) from the American Society for Clinical Pathology (ASCP). This certification further enhanced their expertise in the medical field.

Continuing their education, Kongbouakhay enrolled in the Harvard Medical School Online HMX Program, specializing in various subjects including Immunology, Physiology, Biochemistry, Genetics, and Pharmacology. They commenced their studies at Harvard Medical School in 2021 and are currently active in the program.